Functional restoration of WT-TP53 may induce the regression of cervical carcinomas, which can be achieved by abrogating the expression of the E6 or E6/E7 oncogenes, or through cisplatin (cis-diaminedichloroplatinum II; CDDP) or radiation treatment. The gene discussed is TP53; the disease is cervical carcinoma.